Open Monoclonal Technology
Latest round
- Series B
Last raised
- Mar 2011
Total raised
- $4.9M
Investors
- 1
About Open Monoclonal Technology
, operates as a provider of biotechnology products and services that generates human monoclonal antibodies based on transgenic rats.
Who invested in Open Monoclonal Technology
1 investor across 1 round
See all investors in Open Monoclonal Technology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 24, 2011
Amount
$4.9M
Investors
Questions about Open Monoclonal Technology
Who invested in Open Monoclonal Technology?
Open Monoclonal Technology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Open Monoclonal Technology raised?
Open Monoclonal Technology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Open Monoclonal Technology last raise money?
Open Monoclonal Technology's most recent round on record is a Series B, in Mar 2011.
What does Open Monoclonal Technology do?
, operates as a provider of biotechnology products and services that generates human monoclonal antibodies based on transgenic rats.
Where is Open Monoclonal Technology headquartered?
Open Monoclonal Technology is headquartered in Palo Alto, US.
Which VCs invest in companies like Open Monoclonal Technology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Open Monoclonal Technology's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Open Monoclonal Technology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.